226 results on '"Ishibashi, Daisuke"'
Search Results
2. List of contributors
3. Novel Compounds Identified by Structure-Based Prion Disease Drug Discovery Using In Silico Screening Delay the Progression of an Illness in Prion-Infected Mice
4. Administration of FK506 from Late Stage of Disease Prolongs Survival of Human Prion-Inoculated Mice
5. Preparation of siRNA–PLGA/Fabʹ–PLGA mixed micellar system with target cell-specific recognition
6. Electronic excitation spectra of jet-cooled phenyl isocyanate, m-tolyl isocyanate, and p-phenylene diisocyanate: Assignment of the cis and trans rotational isomers.
7. Crystalline chiral condensates off the tricritical point in a generalized Ginzburg-Landau approach
8. A designer molecular chaperone against transmissible spongiform encephalopathy slows disease progression in mice and macaques
9. Identification of Alprenolol Hydrochloride as an Anti-prion Compound Using Surface Plasmon Resonance Imaging
10. Prion-Like Seeding of Misfolded α-Synuclein in the Brains of Dementia with Lewy Body Patients in RT-QUIC
11. RCAS1 increases cell morphological changes in murine fibroblasts by reducing p38 phosphorylation
12. 合成タウ線維脳内接種による3リピートタウ蓄積モデルマウスの検討
13. Development of an Organ-Directed Exosome-Based siRNA-Carrier Derived from Autologous Serum for Lung Metastases and Testing in the B16/BL6 Spontaneous Lung Metastasis Model
14. Investigation of the photovoltaic performance of the polycrystalline silicon p–n junction by a photothermal measurement
15. Chapter 19 - The application of a drug–poly(lactic-co-glycolic acid) hybrid micellar system for drug delivery
16. Targeted Delivery of Miconazole Employing LL37 Fragment Mutant Peptide CKR12-Poly (Lactic-Co-Glycolic) Acid Polymeric Micelles
17. Dextran sulphate inhibits an association of prions with plasma membrane at the early phase of infection
18. Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapy
19. Drug-induced liver injury after allogeneic bone marrow transplantation
20. Enhancing the anticancer efficacy of a LL-37 peptide fragment analog using peptide-linked PLGA conjugate micelles in tumor cells
21. Antimicrobial Activities of LL-37 Fragment Mutant-Poly (Lactic-Co-Glycolic) Acid Conjugate against Staphylococcus aureus, Escherichia coli, and Candida albicans
22. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion
23. Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era
24. European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients
25. Preparation of siRNA–PLGA/Fabʹ–PLGA mixed micellar system with target cell-specific recognition
26. Assignment of the First 275-nm Absorption System of Phenyl Isocyanate by Quantum-Chemistry Calculation
27. Liquid–liquid phase separation of full-length prion protein initiates conformational conversion in vitro
28. Phase transition of prion protein initiates proteinase K resistant amyloid formation
29. Comparison of Single- and Repeated-Ischemia-Induced Changes in Expression of Flip and Flop Splice Variants of AMPA Receptor Subtypes GluR1 and GluR2 in the Rats Hippocampus CA1 Subregion
30. Immunization with recombinant bovine but not mouse prion protein delays the onset of disease in mice inoculated with a mouse-adapted prion
31. Mucosal immunogenicity of prion protein fused with heat-labile enterotoxin B subunit
32. Post-ischemic treatment with Toki-shakuyaku-san (Tang-gui-shao-yao-san) prevents the impairment of spatial memory induced by repeated cerebral ischemia in rats
33. Generation, optimization and characterization of novel anti-prion compounds
34. Enhanced mucosal immunogenicity of prion protein following fusion with B subunit of Escherichia coli heat-labile enterotoxin
35. Prion protein interacts with the metabotropic glutamate receptor 1 and regulates the organization of Ca2+ signaling
36. Liquid-liquid phase separation of full-length prion protein initiates conformational conversion in vitro
37. Novel Compounds Identified by Structure-Based Prion Disease Drug Discovery Using In Silico Screening Delay the Progression of an Illness
38. Postmortem Quantitative Analysis of Prion Seeding Activity in the Digestive System
39. Hyperefficient PrPSc amplification of mouse-adapted BSE and scrapie strain by protein misfolding cyclic amplification technique
40. Prion-conformation-specific human antibodies established from phage display library
41. Protective Effect of Buckwheat Polyphenols Against Long-Lasting Impairment of Spatial Memory Associated With Hippocampal Neuronal Damage in Rats Subjected to Repeated Cerebral Ischemia
42. Effect of Nilvadipine on the Cerebral Ischemia-Induced Impairment of Spatial Memory and Hippocampal Apoptosis in Rats
43. Protective Role of the Host Innate Immune System in Prion Pathogenesis
44. Type I interferon protects neurons from prions inin vivomodels
45. Newly Developed MEMS Print Heads for Industrial Inkjet Applications
46. Structure-based drug discovery for combating influenza virus by targeting the PA–PB1 interaction
47. Prion-Like Seeding of Misfolded α-Synuclein in the Brains of Dementia with Lewy Body Patients in RT-QUIC
48. Type I interferon protects neurons from prions in in vivo models.
49. Involvement of human MxA protein expressed by the influenza virus in Parkinson's disease
50. Structure-Based Drug Discovery for Prion Disease Using a Novel Binding Simulation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.